Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Carisma Therapeutics Inc (NASDAQ: CARM) closed at $0.19 down -11.52% from its previous closing price of $0.22. In other words, the price has decreased by -$11.52 from its previous closing price. On the day, 0.57 million shares were traded.
Ratios:
For a deeper understanding of Carisma Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.48 and its Current Ratio is at 1.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on December 12, 2024, Downgraded its rating to Neutral and sets its target price to $1 from $10 previously.
On April 11, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 11, 2024, with a $6 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.41.
Stock Price History:
Over the past 52 weeks, CARM has reached a high of $1.90, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is -34.67%, while the 200-Day Moving Average is calculated to be -71.70%.
Shares Statistics:
A total of 41.75M shares are outstanding, with a floating share count of 21.12M. Insiders hold about 49.46% of the company’s shares, while institutions hold 11.61% stake in the company.
